# CMV-TCR-T Cells for CMV Infection After Allogenic HSCT

> **NCT05140187** · PHASE1 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 12 (estimated)

## Conditions studied

- CMV Infection After Allogenic HSCT

## Interventions

- **BIOLOGICAL:** CMV-TCR-T cells

## Key facts

- **NCT ID:** NCT05140187
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05140187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05140187, "CMV-TCR-T Cells for CMV Infection After Allogenic HSCT". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05140187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*